IBSA Institut Biochimique SA
IBSA Group is a multinational pharmaceutical company headquartered in Lugano, Switzerland
The production facilities and R&D labs are distributed in Switzerland, Italy, France and China.
IBSA operates in more than 90 countries and 5 continents with 17 subsidiaries in Europe, China and the USA, and employs over 2,000 collaborators distributed among our headquarters, subsidiaries and manufacturing plants.
IBSA holds 90 patent families and many others in development, with a diversified portfolio covering 10 different therapeutic areas.
It is one of the major players worldwide in the field of Reproductive Medicine and one of the world's leaders in hyaluronic acid-based products.
IBSA has 4 pillars:
Corporate Documents
News

23.03.2023
EAU Congress 2023: IBSA’s commitment between multidisciplinary approach and patients’ awareness

17.03.2023
Telling the emotion of being a dad: the appointment with #IBSAVoices is back

08.03.2023
On the occasion of March 8, we give a voice to the women of IBSA, with the #IBSAVoices project

02.03.2023
Alberto Bona wins the RORC Caribbean 600 in Class40: the new season of Sailing into the Future. Together promises to be full of emotions

23.02.2023
Pharma cybersecurity: IBSA's commitment to ensure continuity for patients

16.02.2023
Parole Fertili (“Fertile Words”): the digital story-sharing project of international scope

09.02.2023
IBSA at the 24th edition of the ESSM

02.02.2023
IBSA at the IMCAS World Congress 2023: innovation and new perspectives for the future of Aesthetic Medicine

26.01.2023